Moderna Says Its COVID-19 Vaccine Is, Safe and Effective, in 12- to 17-Year-Olds.
On Tuesday, Moderna announced the results of their
Phase 2 trial of the administration of their COVID-19
vaccine to..
Credit: Wibbitz Top Stories Duration: 01:02Published
Moderna's COVID-19 vaccine was found to be effective in adolescents aged 12-17 and showed no new or major safety problems in a clinical trial, the developer said on Tuesday, potentially setting the..
Moderna’s Covid-19 two-dose vaccine appears 100 percent effective in adolescents according to newly released data from the company’s Phase 2/3 clinical trial. Veuer’s Chloe Hurst has the story!